{"nct_id":"NCT02437136","title":"Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2015-08-26","start_date_type":"ACTUAL","primary_completion_date":"2022-09-29","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-29","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["SNDX"]}